American International Group’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,012
Closed -$723K 2201
2024
Q1
$723K Sell
14,012
-120
-0.8% -$5.89K ﹤0.01% 1470
2023
Q4
$570K Buy
14,132
+609
+5% +$17.9K ﹤0.01% 1587
2023
Q3
$377K Buy
13,523
+481
+4% +$14.3K ﹤0.01% 1764
2023
Q2
$376K Buy
13,042
+1,581
+14% +$35.2K ﹤0.01% 1819
2023
Q1
$191K Buy
11,461
+1,721
+18% +$24.3K ﹤0.01% 2135
2022
Q4
$123K Sell
9,740
-35
-0.4% -$426 ﹤0.01% 2406
2022
Q3
$117K Buy
9,775
+137
+1% +$1.88K ﹤0.01% 2462
2022
Q2
$136K Buy
9,638
+929
+11% +$12.3K ﹤0.01% 2416
2022
Q1
$108K Buy
8,709
+4,285
+97% +$51.4K ﹤0.01% 2566
2021
Q4
$50K Sell
4,424
-132
-3% -$1.59K ﹤0.01% 2960
2021
Q3
$58K Buy
+4,556
New +$62.7K ﹤0.01% 2963

Other funds holding RXST

American International Group's RXST Position: Q2 2024 in Review

American International Group sold out of RxSight (RXST) in Q2 2024, closing a stake of 14,012 shares — an estimated $723K sold.

American International Group first reported a position in RXST in Q3 2021 and held it in 11 quarters. The position peaked at $723K in Q1 2024. 228 funds tracked by Wall St. Rank hold RXST as of Q2 2024.

  • American International Group reported no remaining RxSight position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 14,012 RxSight shares in Q2 2024, an estimated $723K.
  • American International Group first reported a position in RxSight in Q3 2021 and held it in 11 quarters.
  • American International Group's RxSight position peaked at $723K in Q1 2024.
  • 228 funds tracked by Wall St. Rank held RxSight as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.